Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 5823 Results
March 31, 2026
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
$5.6 Billion
March 30, 2026
iBase-t Announces Strategic Growth Investment from TA to Accelerate AI-Powered Digital Manufacturing and MRO Transformation in Aerospace & Defense
Undisclosed
March 27, 2026
Banca Progetto successfully completes €750m recapitalization from Intesa Sanpaolo, UniCredit, Banco BPM, Monte dei Paschi di Siena and BPER Banca (the "5 Banks"), with the support of the FITD, alongside the de-risking of a €2,100m GBV NPE portfolio to Funds subscribed by AMCO and the 5 Banks.
$3.2 Billion
March 27, 2026
Lazard Advises Aristotle Exchange DCM and DCO on Sale to Underdog
Undisclosed
March 24, 2026
Bansk Group to Acquire So Good So You, A Category-Leading Wellness Shot and Beverage Brand
Undisclosed
March 23, 2026
U-Power Group Acquires CERVA Group and Successfully Amends Its Senior Facility Agreement
Undisclosed
March 20, 2026
Falfurrias Launches Crosslakes Next Growth Phase Through Single-Asset Continuation Fund Led by Leonard Green & Partners
Undisclosed
March 17, 2026
Stephen Smith and Smith Financial Corporation acquire minority stake in The Economist Group
Undisclosed
March 16, 2026
Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its MultiProduct Specialty Commercial Platform
$1.3 Billion
March 12, 2026